Join Dr. Michael Koren, CEO and Executive Director of MedEvidence, to explore how education and transparency can reshape the public’s understanding of clinical research. Dr. Koren shares his passion for putting patient welfare first and highlights how Med Evidence empowers individuals to make informed decisions about participating in trials. He discusses the importance of building trust, breaking down misconceptions, and helping communities see research as a valuable care option. Tune in to discover how storytelling, visibility, and patient engagement are helping redefine the relationship between the public and clinical research.

Sit down with Kate Shaw, Founder and CEO of Innovative Trials, to explore how humanized, bespoke approaches are reshaping patient recruitment and retention in clinical research. Kate breaks down the difference between one-to-one, in-country support and automated recruitment systems, showing how local expertise and cultural understanding can dramatically improve trial outcomes. You’ll also hear how the Patient Support Center and dedicated patient navigators guide participants step by step, ensuring they feel informed, respected, and cared for throughout the trial. This episode uncovers how personalized strategies not only boost recruitment success but also lighten the load for sites and create a more meaningful patient experience.

Early investment in proper training doesn't just benefit new staff—it strengthens your entire organization and the research ecosystem. SCRS is ready to tackle industry-wide training gaps, transforming research assistants, coordinators, and business teams into confident contributors. Learn how this foundational knowledge accelerates success and helps your team navigate challenges with clarity and purpose.

Save your seat today for the hands-on "Back to Basics" workshop at the Global Site Solutions Summit this September in Orlando. This intensive training equips research newcomers with must-have skills to thrive in clinical trials.

Andrew Kimball, Executive Vice President of Strategic Commercial Relationships at Velocity Clinical Research, highlights the growth and initiatives of his organization, which is currently the largest dedicated research site organization in the world. Andrew also shares insight on Velocity's acquisition of Meridian Clinical Research and the benefits of joining a site network.

What is the best way for clinical research sites to find new trials and establish productive industry relationships? Scott Whitt, General Manager of Triad Clinical Trials, discusses business development best practices that have worked for his site, and how sites can develop strategic industry alliances.

Todd Albin, Chief Executive Officer, Cedar Health Research, joins us to discuss a trend many clinical research sites have been experiencing with their budget and CTA negotiations with sponsors.

This episode will highlight how this practice impacts site sustainability, as well as our studies and our patients, and some ways sites and sponsors can come to a mutually beneficial solution.

 Access the SCRS Site Invoiceables Toolkit at myscrs.org/site-invoiceables-toolkit.

The SCRS Digital Innovation Initiative decentralized trials workstream recently released a Best Practices and Recommendations for Site Participation on Decentralized Trials guide. Deena Bernstein, Vice President Customer Success at Datacubed Health , and Karen McIntyre, Senior Director, Patient Innovation Centre at Parexel, share how this resource was developed and how sites can utilize it effectively. 

We'll also discuss what should sites consider before initiating a trial with decentralized elements, and advice for sites that may be hesitant to engage these types of technologies.

In this episode, we are proud to highlight our 2022 Eagle Award sponsor recipient,  Merck. Jennifer Sheller, AVP, Clinical Trial Operations Leader with Merck discusses some of the site-focused programs her organization put in motion to earn the award and their plans to progress those initiatives. Jennifer also discusses Merck's response to the SCRS Open Letter to Industry Partners on sites' workforce and inflationary challenges, and what they took away from the SCRS Global Site Solutions Summit.

SCRS is hosting the second annual Diversity Site Solutions Summit in a few short weeks! Jackie Kent, VP of Strategy and Special Projects and Diversity with SCRS, and Kim Ribeiro, Head of Diversity & Patient Inclusion at AbbVie and co-chair of the SCRS Diversity Awareness Program discuss why an event like this is important for the industry, what makes this year's Summit different, and some of the exciting sessions to look forward to.  

SCRS Oncology Program participants Peter Fredette, Director, Clinical Partnerships Liaison with EQRx and Dan Otap, Principal, Alliance and Partnerships Lead at Genentech share information about helpful oncology resources for sites as well as some exciting new topics they are looking forward to discussing at this year's Global Oncology Site Solutions Summit.

If your site participates in oncology research, be sure to make your voice heard in the Oncology Site Landscape Survey today!

Unfunded, yet essential, study activities are a longstanding problem for the sustainability of studies and clinical research sites. These types of invoiceables, often called hidden costs, are typically not accounted for in the study budgeting process which can be detrimental to long-term site sustainability.  In this episode, David Vulcano, Honorary President, SCRS and Chris Hoyle, Executive Director, Elite Research Network, share information about the SCRS Site Invoiceables Toolkit created to help sites understand common billable items that a site should consider when assessing costs associated with a clinical trial. 

Dr. Queen Adaugo Ohandjo, Patient Advocate and Consultant with Proof Clinical Research, discusses how operational efficiencies at the clinical research site level can enable patient engagement and better patient outcomes. Learn how clinical trials can be designed to be more inclusive for diverse patients and how industry partners can support sites in these efforts to ensure successful trial outcomes.

Read more on this topic from Dr. Adaugo Ohandjo in the SCRS InFocus Newsletter.

Ellen Price, Senior Director of Patient Experience for Velocity Clinical Research, discusses insights from a patient experience survey they conducted with thousands of clinical trial participants. Ellen shares how they gathered the data, some surprising responses, and how other sites can garner participant feedback.

Read the white paper for more survey insights at https://velocityclinical.com/news

Sit down with Rick Ward, Chief Commercial Officer at CRIO, to discuss the emerging concept of central eSource in clinical research. Rick explains how this model, which builds on the traditional eSource framework, can enhance standardization, streamline data collection, and reduce the burden of manual transcription. The conversation highlights the importance of site-driven technology, the flexibility required for real-world implementation, and the need for strong support infrastructure. Explore how CRIO’s approach is reshaping source documentation and creating new opportunities for both sites and sponsors.

Most of us are aware of the telltale signs of heart disease in men. But what about women? Diana Reedie, Director, Clinic Management & Operations at LMC Healthcare and Vivienne van de Walle, Owner of PT&R, share their unique patient and physician perspectives on what women should know about cardiovascular disease. Listen as they highlight some of their personal experiences and advice as well as what the healthcare industry is still learning about women's heart health.

In honor of American Heart Month, we spoke with Dr. Michael Koren, Medical Director and CEO of ENCORE Research Group, as he shares his top tips for heart health – especially for busy professionals working in the clinical research industry. Dr. Koren also explores how cardiovascular research and treatment have progressed over the past several years as well as some exciting new learnings for this vital therapeutic area.

Nancy Trapp, Sr. Director, Field Management, North America Clinical Operations at Novo Nordisk, joins us to discuss why collaborating with clinical research sites is vital to her organization's success. Hear what Novo Nordisk is working on and how it will impact sites.

DM Clinical Research, recipient of the 2022 Excellence in Patient Centricity Award, joins us to highlight some of the programs they put in place to earn the prestigious award.

Hera Arham, Director, Marketing & Patient Engagement at DM Clinical Research, shares how they identified the issues patients were facing, the practices they deployed, and advice for sites and industry partners that want to implement more patient-centric practices.

SCRS recently hosted the European Site Solutions Summit in Lisbon, Portugal, where speakers shared stories about how the conflict in Ukraine is impacting clinical trials and patients. Roman Fishchuk, Head of Clinical Trials Department at Central City Clinical Hospital in Ukraine, shares his perspective on the current status of clinical trials in Ukraine and how the war has affected them. 

Mike Clay, Chief Operating Officer at Javara, joins us to share more information about the winning recruitment strategy his organization presented at the 2022 Global Site Solutions Summit for the Site Patient Recruitment Innovation Award (SPRIA). Mike discusses how Javara developed their idea, what recruitment methods had the most impact, and the value of collaboration for better community engagement.

CRAs have a notoriously difficult job in the clinical research landscape. Daniel Paucar, Manager, Strategic Site Networks, US EPON Operations Lead at IQVIA, joins us to share how the role has evolved over the past several years as well as the conveniences and challenges with remote monitoring. Hear Daniel's insight on how sites and CRAs can better work together for more efficient monitoring.

What is the industry doing to address the issue of staffing challenges for clinical research sites? In this episode 2022 Site Tank winner, Kate Marusina, Ph.D., MBA, Director of the Clinical Trials Office of UC Davis Clinical and Translational Science Center, shares insights on their innovative program presented at the 2022 Global Site Solutions Summit. Learn more about Site Tank at https://sitesolutionssummit.com/site-tank/

Scott Gray, CEO of Clincierge, highlights statistics from an independent, IRB-approved survey of patients and caregivers regarding participation in clinical trials. Learn about the financial risks of patient dropouts and trial delays, plus practical strategies for making trial participation easier and encouraging patient retention. 

Has your clinical research site thought about joining a site network? Mark Blumling, CEO and Founder of Headlands Research, shares what to expect when joining a network and how to prepare your site for acquisition. Mark also discusses how their site network approaches diversity, equity and inclusion initiatives.

Clinical research in Europe presents unique challenges, from navigating country-specific regulations to addressing language barriers and patient travel logistics. Scout’s Moisha Platto and Courtney Dodge share how tailored solutions are enhancing clinical trial efficiency across Europe and what this means for sites, sponsors, and patients. Hear strategies for improving patient engagement, streamlining reimbursements, and ensuring compliance with regional regulations. 

SCRS is excited to reunite with our European community in-person in Lisbon, Portugal this November! Viviënne van de Walle, co-founder of PT&R and SCRS European Site Solutions Summit chair, shares how clinical research has changed since we last hosted the European Summit in March of 2019 and some of the sessions she is most looking forward to this year.  Plus, learn how to maximize your experience at the Summit to ensure you leave with valuable takeaways and lasting connections. Learn more about the European Summit and register at eusitesolutionssummit.com.

Danielle Mitchell, CEO and Founder of Black Women in Clinical Research, shares why she started her organization and how they are working to advance diversity in the clinical research industry. Tune in to hear about the panel session she will be participating in at the 2022 Global Site Solutions Summit and why she feels SCRS Summits are different from other industry conferences.

SCRS is quickly approaching its annual Global Site Solutions Summit! This year the Summit will be extra special as we celebrate 10 years of advancing site success. Allyson Small, Chief Operating Officer of SCRS, and David Vulcano, SCRS Honorary President, share how attendees can make the most of their experience while highlighting some of the exciting additions planned for the Summit.  Don't miss what we have in store!

The Association of Clinical Research Organizations (ACRO) is celebrating 20 years since its inception. Doug Peddicord, Ph.D., Executive Director of ACRO, joins us to share his thoughts on some of the biggest changes in clinical research over the last two decades and how they have worked with SCRS through the years. Learn more about ACRO's session at the Global Site Solutions Summit and what role the site voice has in ACRO's important work.

Medidata recently hosted a Site Advocacy Group (SAG) where SCRS member sites offered feedback on budgeting and payments for clinical trials. Tina Mincher, Director, Client Strategy, Clinical Trial Financial Management at Medidata and Edward Czerwinski, Senior Medical Director, FutureMeds, join us to discuss what was learned from a service provider and site perspective. Hear some of the top financial struggles for sites and how sites and industry partners can work together for better transparency with trial budgets and payments.

Amanda Wright​, Chief Development Officer at Javara, a new SCRS Global Impact Partner, shares insights about integrated research organizations (IROs), clinical research as a care option, and how industry partnerships can streamline clinical trials. Learn what initiatives Javara is working on and why joining SCRS was a priority for their organization.

SCRS is excited to welcome Transformative Pharmaceutical Solutions (TPS) to the Global Impact Partner program! Jeff Repper, Executive Vice President, and Kyle Given, EVP, Account Management share why their organization decided to become a GIP and how they want to work with clinical research sites and industry partners to improve the research experience for all.

Technology has the power to reduce the burden on overworked sites–but only if that technology is well-integrated. Catherine Gregor, Chief Clinical Trial Officer at Florence Healthcare, shares insights from her session at the 2022 Global Oncology Site Solutions Summit on challenges and opportunities with site-centric technology. Listen as Catherine shares how sites and Sponsors can ensure they are working together to develop mutually beneficial solutions.

Commemorating a decade since the organization's inception, SCRS spoke with one of our first clinical research site members, Richard Pollack with Evolution Research Group.  Dr. Pollack shines a light on how he was introduced to SCRS and some of his fond memories with the organization while reflecting on how the industry has changed.

Decentralized clinical trial (DCT) technology has the opportunity to create more effective, efficient, and accessible clinical trials. Now that research sites have more experience with these systems, we also have a better understanding of their challenges and opportunities. Craig Lipset, advisor and founder of Clinical Innovation Partners and co-chair of the Decentralized Trials & Research Alliance shares what the clinical trials industry has learned about DCTs and how we can move forward together.

SCRS’s Karri Venn takes a deep dive into the current state of clinical research coordinator salaries with Stacie Merritt, Director at Ascension St. John Clinical Research Institute. We analyze compensation trends, including salary ranges and bonuses, and how organizations can remain competitive in a rapidly evolving job market. Learn how sites of all sizes and types are compensating their workforce and the key factors influencing coordinator pay. Don’t miss this essential conversation packed with data-driven insights to help your site refine its compensation strategy, improve staff retention, and stay ahead in a competitive workforce landscape. 

The clinical research industry is currently seeing an unprecedented rise of sites facing financial burden due to increasing costs of staffing and supplies. Now more than ever, it's critical that sites learn what actions they can take to ensure they understand what they are agreeing to in clinical trial agreements and what flexibility they have. Daniel Fox, Ph.D., founder and CEO of the Clinical Research Payment Network,  shares what to look for in CTAs to ensure they are in the site's best interest and how to establish a mutual relationship of trust with industry partners.

SCRS recently held its fourth annual Global Oncology Site Solutions Summit in Austin, Texas. It was an incredible two-day event with actionable insights and best practices specific to oncology clinical research. In this episode, we speak with Peter Fredette, a long-standing member of the SCRS Oncology program and our new Global Oncology Summit chair, to discuss some highlights from this year's conference and what we can expect for the future of the program.

Patient-centricity has been a hot topic in clinical research. Recently the industry has realized that to truly be patient-centric, you must also be site-centric. Deena Bernstein, Vice President of Customer Success at Datacubed, discusses what it means to be site and participant centric in clinical trials and how to reduce the burden of technology for both patients and sites.

The implementation of decentralized tools and technologies has drastically changed study start-up and training requirements that have placed an additional burden on clinical research sites. SCRS spoke with Todd Albin, CEO of Cedar Health Research to discuss how sites can prepare for these changes and ensure all industry stakeholders are working together to ensure efficiency and sustainability with technology in trials.

The 2022 Australia-New Zealand Summit is quickly approaching! ANZ Summit chairs Cheryl-Ann Hawkins, Chief Operating Officer at Emeritus Research and Tam C. Nguyen, Deputy Director of Research at St. Vincent’s Hospital Melbourne, share what they are most excited about for this year's Summit, sessions they are looking forward to, and how to maximize your experience. Learn more and register today at https://apsitesolutionssummit.com

Holdback payments evolved as a way for industry sponsors and CROs to ensure that their clinical research sites were completing the necessary work throughout a trial. However, holdback payments have been a long-standing issue for sites. 

Vivienne van de Walle, co-founder of PreCare Trial & Recruitment, shares lessons learned from working with sponsors and CROs to eliminate this practice, and tips for sites to successfully negotiate to have their study costs covered.

The industry is currently facing unprecedented macroeconomic issues including substantial staffing challenges and inflationary pressures.  In response, SCRS formed a task force committee, which provides resources for both sites and industry to collaborate to address these issues.

David Vulcano, SCRS Honorary President and VP of Clinical Research Compliance & Integrity at HCA Healthcare speaks with William Smith, co-chair of the SCRS task force and CEO of Alliance Speciality Research and Jeff Kingsley, CEO of Centricity Research and task force member, to talk through what the committee is doing to mitigate these challenges and how our industry partners can help.

In this episode of SCRS Talks, we spoke with Jane Myles, VP of Clinical Trial Innovation at Curebase, a new Global Impact Partner. Jane shares what research sites should know about decentralized trial technology and some initiatives Curebase is working on that will impact sites.

Join SCRS in welcoming Clinical ink to the Global Impact Partner (GIP) program! Syed Faridi, Senior Director of Business Development, and Lane Nichols, Executive Vice President, Head of Product, share why they decided to become a GIP and what they see for the future of their relationship with clinical research sites.

This Clinical Trials Day is especially meaningful to SCRS because it is the same day as SCRS' first-ever Diversity Site Solutions Summit.  To share a preview of some of the critical discussions that we'll cover at the Summit, we are joined by Lorena Kuri from Bristol Myers Squibb, Lloryn Hubbard from PPD, and Jaleeysa King from Greenphire. We'll highlight some of the industry's biggest wins and opportunities to improve diverse representation in trials.  Plus, they'll share how they plan to partner with sites to meet the industry's diverse enrollment goals.

Clinical trials must represent the communities they serve—and the SCRS IncluDE Program is equipping research sites to make that a reality. In this episode, SCRS' Kathy Mickel sits down with Kim Ribeiro, IncluDE Program co-chair, to discuss how sites and industry partners can make trials more accessible to all communities. We tackle the importance of staying focused on the science, cutting through the noise, and having real conversations about what’s working (and what’s not). Tune in to hear why the IncluDE Site Solutions Summit is a must-attend event for sites, sponsors, and solution providers—and how you can be part of the collective shaping the future of representative research.

Please join us in welcoming Aspen Insights to the SCRS Global Impact Partner program! Walter Storm, co-founder and CEO of Aspen Insights shares how his organization is listening to sites to understand their pain points and developing solutions to resolve them using data analytics. Listen to hear some initiatives Aspen Insights is working on to support site sustainability and streamlined trial enrollment through applied data science, artificial intelligence, and machine learning.

In this episode, SCRS is excited to showcase H1, one of SCRS' newest Global Impact Partners. We spoke with Adam Wyckoff, Director of Product Management, Clinical Trials, who shares why H1 believes listening to site voices is important and how they plan to work more closely with research sites in the future.  For more information about H1, please reach out to H1 at elizabeth.schwartz@h1.co.

SCRS is celebrating 10 years since our founder, Christine K. Pierre, officially formed the organization! We spoke with Clare Grace, Chief Patient Officer at one of SCRS' first Global Impact Partners, Parexel, to look back on why SCRS was created and how it has evolved through the years. We also explore current industry challenges SCRS is working to address, including how prioritizing site success impacts everyone in clinical research.